Production (Stage)
BioAtla, Inc.
BCAB
$0.3896
$0.00832.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.33M | -14.88M | -10.59M | -21.07M | -23.23M |
| Total Depreciation and Amortization | 183.00K | 228.00K | 228.00K | 229.00K | 240.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -235.00K | 1.12M | 2.19M | 2.50M | 2.30M |
| Change in Net Operating Assets | -902.00K | -3.25M | 3.03M | -846.00K | -10.13M |
| Cash from Operations | -16.29M | -16.78M | -5.13M | -19.19M | -30.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 9.31M | 0.00 | 244.00K | -- |
| Repurchase of Common Stock | -29.00K | 0.00 | -14.00K | -19.00K | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -366.00K | -- | -- | -- | -- |
| Cash from Financing | -395.00K | 9.31M | -14.00K | 225.00K | -13.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.68M | -7.47M | -5.15M | -18.97M | -30.84M |